Skip to main content
. Author manuscript; available in PMC: 2008 May 15.
Published in final edited form as: Bioorg Med Chem. 2007 Mar 12;15(10):3430–3436. doi: 10.1016/j.bmc.2007.03.016

Figure 4.

Figure 4

A typical radioactivity profile of reversed-phase HPLC of final [211At]MABG dose obtained by the kit method. For this a Waters' XTerra C18 column was eluted isocratically with 0.1% TFA in 80/20 water/CH3CN at a flow rate of 1 ml/min.